Hypertension Treatment and Control in Five European Countries, Canada, and the United States

Hypertension

Volumn 43, Issue 1, 2004, Pages 10-17

  Wolf Maier, Katharina ^a   Cooper, Richard S ^a   Kramer, Holly ^a   Banegas, José R ^b   Giampaoli, Simona ^c   Joffres, Michel R ^d   Poulter, Neil ^e   Primatesta, Paola ^f   Stegmayr, Birgitta ^g   Thamm, Michael ^h  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d DALHOUSIE UNIVERSITY   (Canada)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^g UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^h ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Antihypertensive therapy; Blood pressure monitoring; Cross sectional studies; Hypertension, detection and control; Models, statistical

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CANADA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; FEMALE; GERMANY; HEALTH SURVEY; HUMAN; HYPERTENSION; ITALY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SPAIN; SWEDEN; UNITED KINGDOM; UNITED STATES;

EID: 9144248446     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000103630.72812.10     Document Type: Review

References (36)

1. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349:1436-1442.
2. National Heart, Lung, and Blood Institute. Reflections on hypertension control rates. Arch Intern Med. 2002;162:131-132.
3. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, Brown C, Roccella EJ. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: data from the health examination surveys, 1960 to 1991. Hypertension. 1995;26:60-69.
4. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, Md: National Institutes of Health; National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program; NIH publication No. 98-4080. 1997.
5. Cooper R, Cutler J, Desvigne-Nickens P, Fortmann S, Friedman L, Havlik R, Hogelin G, Marler J, McGovern P, Morosco G, Mosca L, Pearson T, Stamler J, Stryer D, Thom T. Trends and disparities in coronary heart disease, stroke and other cardiovascular diseases in the United States: findings of the National Conference on CVD Prevention. Circulation. 2001;102:3137-3147.
6. Coca A. Actual blood pressure control: are we doing things right? J Hypertens. 1998;16(suppl 1):45-51.
7. Guidelines Subcommittee. 1999 World Health Organization- International Society of Hypertension guidelines for the management of hypertension. J Hypertens. 1999;17:151-183.
8. Ramsay L, Williams B, Johnston G, MacGregor G, Poston L, Potter J, Poulter N, Russell G. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society. J Hum Hypertens. 1999;13:569-592.
9. Campbell NR. The Canadian Hypertension Recommendations Working Group. The 2001 Canadian Hypertension Recommendations: what is new and what is old but still important. Can J Cardiol. 2002;18:591-603.
10. Deutsche Hochdruckliga. Deutsche Hypertonie Gesellschaft. Leitlinien für die Prävention, Erkennung, Diagnostik und Therapie der arteriellen Hypertonie. Dtsch Med Wschr. 2001;126(suppl 4):201-238. [German Hypertension Society. Guidelines for the prevention, recognition, diagnosis and treatment of arterial hypertension.]
11. Ramsay LE, Wallis EJ, Yeo WW, Jackson PR. The rationale for differing national recommendations for the treatment of hypertension. Am J Hypertens. 1998;11:79-88.
12. Chalmers J. Enhancing risk stratification in hypertensive subjects: how far should we go in routine screening for target organ damage? J Hypertens. 2002;20:1255-1257.
13. Cuspidi C, Ambrosioni E, Mancia G, Pessina AC, Trimarco B, Zanchetti A. Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey. J Hypertens. 2002;20:1307-1314.
14. Primatesta P, Brooks M, Poulter NR. Improved hypertension management and control: results from the Health Survey for England 1998. Hypertension. 2001;38:827-832.
15. Thamm M. Blood pressure in Germany: current status and trends. Gesundheitswesen. 1999;61:90-93.
16. Banegas JR, Rodriguez-Artalejo F, de la Cruz Troca JJ, Guallar-Castillon P, del Rey Calero J. Blood pressure in Spain: distribution, awareness, control, and benefits of a reduction in average pressure. Hypertension. 1998;32:998-1002.
17. Joffres MR, Ghadirian P, Fodor JG, Petrasovits A, Chockalingam A, Hamet P. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens. 1997;10:1097-1102.
18. Rehm J, Sempos C, Kohlmeier L, Myers G, Thefeld W, Gunter E, Thamm M, Dortschy R, Murphy R, Feinleib M, Hoffmeister H. A comparison of serum total cholesterol levels and their determinants between the Federal Republic of Germany and the United States. Eur J Epidemiol. 2000;16:669-675.
19. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense H, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodriguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F. Hypertension and blood pressure levels in 6 European countries, Canada, and the US. JAMA. 2003;289:2363-2369.
20. Giampaoli S, D'Vanuzzo D. Atlas of cardiovascular diseases. 1st ed. Ital Heart J. 2003;4(suppl 4):1-12.
21. Stegmayr B, Harmsen P, Rajakangas A, Rastenyte D, Sarti C, Thorvaldsen P, Tuomilehto J. Stroke around the Baltic Sea: incidence, case fatality and population risk factors in Denmark, Finland, Sweden and Lithuania. Cerebrovasc Dis. 1996;6:80-88.
22. Persson M, Carlberg B, Mjorndal T, Asplund K, Bohlin J, Lindholm L. The 1999 WHO/ISH Hypertension Guidelines: 1999 WHO/ISH Guidelines applied to a 1999 MONICA sample from northern Sweden. J Hypertens. 2002;20:29-35.
23. Burt VL, Whelton P, Roccella EL, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25:305-313.
24. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991;121:293-298.
25. Haq IU, Ramsay LE, Yeo WW, Jackson PR, Wallis EJ. Is the Framingham risk function valid for northern European populations? a comparison of methods for estimating absolute coronary risk in high risk men. Heart. 1999;81:40-46.
26. Ramsay LE, ul Haq I, Yeo WW, Jackson PR. Interpretation of prospective trials in hypertension: do treatment guidelines accurately reflect current evidence? J Hypertens Suppl. 1996;14:187-194.
27. Fagard RH, Van Den Enden M, Leeman M, Warling X. Survey on treatment of hypertension and implementation of World Health Organization/International Society of Hypertension risk stratification in primary care in Belgium. J Hypertens. 2002;20:1297-1302.
28. EUROASPIRE I and II Group. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet. 2001;357:995-1001.
29. WHO Collaborating Center on Surveillance of Cardiovascular Disease. Available at: http://198.103.246.234/gcvi/default.htm. Accessed February 3, 2003.
30. Lloyd-Jones DM, Evans JC, Larson MG, O'Donnell CJ, Roccella EJ, Levy D. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension. 2000;36:594-599.
31. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345:479-486.
32. Lloyd-Jones DM, Evans JC, Larson MG, Levy D. Treatment and control of hypertension in the community: a prospective analysis. Hypertension. 2002;40:640-646.
33. Wong ND, Thakral G, Franklinn SS, L'Italien GJ, Jacobs MJ, Whyte JL, Lapuerta P. Preventing heart disease by controlling hypertension: impact of hypertensive subtype, stage, age and sex. Am Heart J. 2003;145:888-895.
34. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290:199-206.
35. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981-2997.
36. McAlister FA, Campbell NR, Zarnke K, Levine M, Graham ID. The management of hypertension in Canada: a review of current guidelines, their shortcomings and implications for the future. CMAJ. 2001;164:517-522.